The U.S. Supreme Court has handed down a major administrative-law ruling with immediate consequences for federal agencies, regulated businesses, and the lawyers who advise them.

A new post-grant review at the Patent Trial and Appeal Board is worth watching for practitioners tracking early-life patent challenges and the evolving use of PTAB proceedings against recently issued patents. In PGR2026-00064, titled ShoreShade LLC, the petition was filed on July 1, 2026. The proceeding is now on the radar for patent owners, petitioners, and IP counsel evaluating how aggressively to use post-grant review in high-stakes disputes.

At this stage, the docket caption identifies ShoreShade LLC as the patent owner in the PTAB proceeding.

A federal judge in Washington has preliminarily blocked the Defense Department from forcing New York Times reporters to be accompanied by escorts while they pursue their challenge to Pentagon press-access restrictions, a ruling that signals meaningful judicial skepticism toward the policy under the First Amendment.

The dispute, now pending as NEW YORK TIMES COMPANY et al v. DEPARTMENT OF DEFENSE et al, centers on whether the Pentagon can impose differential access burdens on a major news organization in a way that appears to impede routine newsgathering.

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, putting an America Ugreen Limited patent directly in the PTAB spotlight.

A new inter partes review filed at the Patent Trial and Appeal Board could be one to watch for companies operating at the intersection of life sciences, nutraceuticals, and consumer health. In IPR2026-00400, the proceeding is captioned Thorne Research, Inc. and was filed on June 22, 2026.

At this early stage, the PTAB docket signals that a patent challenge involving Thorne Research is underway, but practitioners should note that key details—including the specific patent claims at issue, the identity of the petitioner and patent owner as reflected in the styled papers, and the precise invalidity combinations asserted—may develop as the record fills out.

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, in a matter captioned America Ugreen Limited. While the publicly available docket caption immediately identifies Ugreen as a party, patent professionals will want to watch for the petition, mandatory notices, and patent owner filings to clarify the full party alignment, the challenged claims, and the commercial context behind the dispute.

At this stage, the key takeaway is procedural as much as substantive: a post-grant review is only available for patents subject to the AIA’s first-inventor-to-file regime and allows challengers to press a broader range of invalidity theories than inter partes review.

The Supreme Court’s June 23, 2026 disposition in No. 24-856 is notably concise: the judgment below was reversed and the case remanded. At least from the docket entry provided, the Court has not supplied an accompanying merits opinion in the materials summarized here. Even so, that procedural posture carries real significance for lawyers tracking the case and for practitioners thinking about next steps in the lower courts.

A reversal and remand means the Supreme Court concluded the lower court’s judgment cannot stand and that further proceedings are required.

Another PTAB proceeding has been filed against ResMed, with IPR2026-00341 entering the Patent Trial and Appeal Board on June 12, 2026. The petition places one of ResMed’s patents under inter partes review, opening a new front in what could become an important dispute for companies operating in the sleep-disorder and respiratory-device space.

At this stage, the publicly available docket identifies the proceeding by the title Resmed Corp., but practitioners will want to monitor the case record closely as the petition, mandatory notices, and related filings further clarify the specific patent claims at issue, the identity of all real parties in interest, and any parallel district court or ITC litigation that may shape the Board’s discretionary-review analysis.

As with any newly filed IPR, the key issues will center on which patent is being challenged, which claims are targeted, and what prior-art grounds are asserted. Typically, petitioners rely on anticipation and obviousness grounds under 35 U.S.C. §§ 102 and 103, supported by combinations of patents, printed publications, and expert declarations.

A new inter partes review, IPR2026-00387, was filed at the Patent Trial and Appeal Board on June 5, 2026, under the caption Optiver US LLC. At this early stage, the proceeding is notable less for a developed merits record and more for what it signals: another PTAB dispute involving a sophisticated market participant, with the potential to touch on commercially important technology and high-stakes parallel enforcement or licensing issues.

Based on the docket currently available, the proceeding names Optiver US LLC as the petitioner.

Another new inter partes review to watch at the Patent Trial and Appeal Board: IPR2026-00387, filed June 5, 2026, and captioned Optiver US LLC. At this early stage, the docket signals the start of a potentially important dispute for companies operating in technology-driven and latency-sensitive markets, but the petition itself will be the key document for practitioners looking to assess the full stakes of the case.

Based on the current docket entry, Optiver US LLC is the petitioner seeking review of an issued U.S. patent.

The Department of Justice has announced that a federal grand jury in the Eastern District of North Carolina has indicted former FBI Director James Comey on charges alleging threats to harm President Donald Trump. Whatever the ultimate merits, the case is immediately significant because it combines a high-profile defendant, allegations involving threats against a sitting or former president, and the likelihood of fast-moving appellate and procedural litigation.

For legal professionals, this is the kind of prosecution that will be watched as closely for its procedural posture as for its political implications.

Samsung Electronics Co., Ltd. has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00337 on April 15, 2026. The proceeding places another potentially significant patent dispute on the PTAB’s docket and gives patent practitioners an early look at what may become an important validity fight involving Samsung as petitioner.

At this stage, the publicly available case caption identifies Samsung Electronics Co., Ltd. as the petitioner, but practitioners should watch the docket closely for the patent owner’s formal identification, the challenged patent number, and the specific claims at issue as those details become more fully reflected in the record.

The U.S. Supreme Court has issued a major First Amendment ruling in Chiles v. Salazar, holding that Colorado’s conversion-therapy law, as applied to a licensed counselor’s talk therapy with minors, regulates speech based on viewpoint and that the lower courts did not apply the required level of constitutional scrutiny. The decision is likely to reshape ongoing litigation over state regulation of licensed professionals and could prompt renewed challenges to similar laws across the country.

The case was brought by counselor Kaley Chiles, who argued that Colorado’s law barred her from engaging in voluntary, client-directed conversations about sexuality and gender identity when those conversations sought outcomes the state disfavored.

Docket Alarm is excited to announce a new integration with Courtroom Insight, a litigation knowledge management solution. The integration is set to improve the way the legal publishing world works together on connecting and sharing data to serve clients with better access to facts and research. Now, Courtroom Insight (CRI) users benefit from Docket Alarm's database of over half a billion documents when browsing expert witness and judicial profiles.

What is Courtroom Insight?

Courtroom Insight helps firms manage litigation knowledge and is used by Am Law 200 law firms so they can combine information about private firms with other important data.

Docket Alarm helps attorneys like you find the legal information you need, faster. Only with more knowledge about cases and lawsuits can you analyze outcomes for a true competitive advantage for your practice.

Our Founder and Managing Director Michael Sander is delivering search tips to help you optimize your search even more using Docket Alarm. Here’s some helpful info about how to search for a case by its subject matter using the tool.

Search Tip: Find a case of a particular type even when there is no good case type field

Sometimes you want to search for a case by its subject matter, but there is no good case "type" or "nature of suit" field that captures this.